Discovery of orteronel (TAK-700), a naphthylmethylimidazole derivative, as a highly selective 17,20-lyase inhibitor with potential utility in the treatment of prostate cancerTomohiro Kaku, Akihiro Tasaka, Takenori Hitaka et al.|Bioorganic & Medicinal Chemistry|2011Cited by 126
C17,20-lyase inhibitors. Part 2: Design, synthesis and structure–activity relationships of (2-naphthylmethyl)-1H-imidazoles as novel C17,20-lyase inhibitorsNobuyuki Matsunaga, Akihiro Tasaka, Tomohiro Kaku et al.|Bioorganic & Medicinal Chemistry|2004Cited by 56
C17,20-Lyase inhibitors I. Structure-based de novo design and SAR study of C17,20-lyase inhibitorsNobuyuki Matsunaga, Akihiro Tasaka, Tomohiro Kaku et al.|Bioorganic & Medicinal Chemistry|2004Cited by 40
Design, synthesis, and biological evaluation of 4-phenylpyrrole derivatives as novel androgen receptor antagonistsSatoshi Yamamoto, Mitsuhiro Ito, Nobuyuki Matsunaga et al.|Bioorganic & Medicinal Chemistry|2011Cited by 19
17,20-Lyase inhibitors. Part 4: Design, synthesis and structure–activity relationships of naphthylmethylimidazole derivatives as novel 17,20-lyase inhibitorsTomohiro Kaku, Akihiro Tasaka, Nobuyuki Matsunaga et al.|Bioorganic & Medicinal Chemistry|2011Cited by 12